Top Key Companies for Sodium Iodide [131I] Oral Solution Market: Jubilant Radiopharma, IBM Micromedex, ANSTO, International Isotopes Inc., China Isotope & Radiation Corporation, Yantai Dongcheng.
Global Sodium Iodide [131I] Oral Solution Market Size was estimated at USD 37539.33 million in 2022 and is projected to reach USD 63968.93 million by 2028, exhibiting a CAGR of 9.29% during the forecast period.
Global Sodium Iodide [131I] Oral Solution Market Overview And Scope:
The Global Sodium Iodide [131I] Oral Solution Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Sodium Iodide [131I] Oral Solution utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Sodium Iodide [131I] Oral Solution Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sodium Iodide [131I] Oral Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Sodium Iodide [131I] Oral Solution market.
Global Sodium Iodide [131I] Oral Solution Market Segmentation
By Type, Sodium Iodide [131I] Oral Solution market has been segmented into:
250 mCi
500 mCi
1000 mCi
By Application, Sodium Iodide [131I] Oral Solution market has been segmented into:
Hyperthyroidism
Thyroid
Regional Analysis of Sodium Iodide [131I] Oral Solution Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Sodium Iodide [131I] Oral Solution Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Sodium Iodide [131I] Oral Solution market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Sodium Iodide [131I] Oral Solution market.
Top Key Companies Covered in Sodium Iodide [131I] Oral Solution market are:
Jubilant Radiopharma
IBM Micromedex
ANSTO
International Isotopes Inc.
China Isotope & Radiation Corporation
Yantai Dongcheng
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Sodium Iodide [131I] Oral Solution Market by Type
5.1 Sodium Iodide [131I] Oral Solution Market Overview Snapshot and Growth Engine
5.2 Sodium Iodide [131I] Oral Solution Market Overview
5.3 250 mCi
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 250 mCi: Geographic Segmentation
5.4 500 mCi
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 500 mCi: Geographic Segmentation
5.5 1000 mCi
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 1000 mCi: Geographic Segmentation
Chapter 6: Sodium Iodide [131I] Oral Solution Market by Application
6.1 Sodium Iodide [131I] Oral Solution Market Overview Snapshot and Growth Engine
6.2 Sodium Iodide [131I] Oral Solution Market Overview
6.3 Hyperthyroidism
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hyperthyroidism: Geographic Segmentation
6.4 Thyroid
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Thyroid: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Sodium Iodide [131I] Oral Solution Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Sodium Iodide [131I] Oral Solution Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Sodium Iodide [131I] Oral Solution Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 JUBILANT RADIOPHARMA
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 IBM MICROMEDEX
7.4 ANSTO
7.5 INTERNATIONAL ISOTOPES INC.
7.6 CHINA ISOTOPE & RADIATION CORPORATION
7.7 YANTAI DONGCHENG
Chapter 8: Global Sodium Iodide [131I] Oral Solution Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 250 mCi
8.2.2 500 mCi
8.2.3 1000 mCi
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hyperthyroidism
8.3.2 Thyroid
Chapter 9: North America Sodium Iodide [131I] Oral Solution Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 250 mCi
9.4.2 500 mCi
9.4.3 1000 mCi
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hyperthyroidism
9.5.2 Thyroid
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Sodium Iodide [131I] Oral Solution Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 250 mCi
10.4.2 500 mCi
10.4.3 1000 mCi
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hyperthyroidism
10.5.2 Thyroid
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Sodium Iodide [131I] Oral Solution Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 250 mCi
11.4.2 500 mCi
11.4.3 1000 mCi
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hyperthyroidism
11.5.2 Thyroid
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Sodium Iodide [131I] Oral Solution Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 250 mCi
12.4.2 500 mCi
12.4.3 1000 mCi
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hyperthyroidism
12.5.2 Thyroid
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Sodium Iodide [131I] Oral Solution Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 250 mCi
13.4.2 500 mCi
13.4.3 1000 mCi
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hyperthyroidism
13.5.2 Thyroid
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Sodium Iodide [131I] Oral Solution Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 250 mCi
14.4.2 500 mCi
14.4.3 1000 mCi
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hyperthyroidism
14.5.2 Thyroid
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Sodium Iodide [131I] Oral Solution Scope:
|
Report Data
|
Sodium Iodide [131I] Oral Solution Market
|
|
Sodium Iodide [131I] Oral Solution Market Size in 2025
|
USD XX million
|
|
Sodium Iodide [131I] Oral Solution CAGR 2025 - 2032
|
XX%
|
|
Sodium Iodide [131I] Oral Solution Base Year
|
2024
|
|
Sodium Iodide [131I] Oral Solution Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Jubilant Radiopharma, IBM Micromedex, ANSTO, International Isotopes Inc., China Isotope & Radiation Corporation, Yantai Dongcheng.
|
|
Key Segments
|
By Type
250 mCi
500 mCi
1000 mCi
By Applications
Hyperthyroidism
Thyroid
|
